About Marley Drug
Marley Drug is a company based in Winston-salem (United States) founded in 2003 was acquired by Medicure in December 2020. Marley Drug offers products and services including Generic Medications, Brand Medications, Bexagliflozin, Soaanz, and Pitavastatin. Marley Drug operates in a competitive market with competitors including Pfizer, AmerisourceBergen, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.
- Headquarter Winston-salem, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Marley Drug
Marley Drug offers a comprehensive portfolio of products and services, including Generic Medications, Brand Medications, Bexagliflozin, Soaanz, and Pitavastatin.
Affordable drugs for chronic conditions like hypertension and mental health
Select brand-name drugs offered at reduced prices directly
Tablet for diabetes management with cost-effective pricing options
Generic torsemide tablet for fluid retention treatment
Tablet to lower cholesterol levels affordably
Funding Insights of Marley Drug
Detailed funding history for Marley Drug
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Marley Drug
Marley Drug has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medicure.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Affordable therapeutics are developed and e-commerce pharmacy services are provided.
|
Locked | Locked | Locked |
Investor details for Marley Drug
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Marley Drug
Investment portfolio details for Marley Drug
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Marley Drug
Detailed financials for Marley Drug
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Marley Drug Comparisons
Peer comparison for Marley Drug
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Marley Drug
Marley Drug operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pfizer, AmerisourceBergen, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| Locked | Locked | Locked |
India's leading healthcare products distribution platform
|
|
| Locked | Locked | Locked |
Wholesaler & distributor of healthcare, medical, and pharmaceutical products
|
|
| Locked | Locked | Locked |
Diversified drugs are distributed by Renee in the United States.
|
Detailed competitors of Marley Drug
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Marley Drug
Complete news archive for Marley Drug
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marley Drug
Marley Drug was founded in 2003.
Marley Drug is headquartered in Winston-salem, United States. It is registered at Winston-salem, North Carolina, United States.
Dave Marley is the current CEO of Marley Drug.
Marley Drug was founded in 2003 and is located in Winston-Salem, United States. Operations are centered on the pharmaceutical sector, where products are supplied to meet distribution needs. Ownership is shared by Elizabeth Marley and Dave Marley, with Dave Marley designated as CEO. Services encompass the provision of pharmaceutical goods across relevant markets, supported by established infrastructure in the region.
Marley Drug's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.
Marley Drug offers Generic Medications, Brand Medications, Bexagliflozin, Soaanz, and Pitavastatin.
Marley Drug has 1 investor. Key investors include Medicure.